| Literature DB >> 28948984 |
Lene Terslev1, Esperanza Naredo2, Philippe Aegerter3, Richard J Wakefield4, Marina Backhaus5, Peter Balint6, George A W Bruyn7, Annamaria Iagnocco8, Sandrine Jousse-Joulin9, Wolfgang A Schmidt10, Marcin Szkudlarek11, Philip G Conaghan4, Emilio Filippucci12, Maria Antonietta D'Agostino13,14.
Abstract
OBJECTIVES: To test the reliability of new ultrasound (US) definitions and quantification of synovial hypertrophy (SH) and power Doppler (PD) signal, separately and in combination, in a range of joints in patients with rheumatoid arthritis (RA) using the European League Against Rheumatisms-Outcomes Measures in Rheumatology (EULAR-OMERACT) combined score for PD and SH.Entities:
Keywords: EULAR; OMERACT; doppler; scoring system; synovitis; ultrasound
Year: 2017 PMID: 28948984 PMCID: PMC5597800 DOI: 10.1136/rmdopen-2016-000427
Source DB: PubMed Journal: RMD Open ISSN: 2056-5933
Definitions of severity grades (0–3) for each elementary component and for the EULAR-OMERACT combined score
| Synovitis | SH (greyscale) | Doppler | Combined score* |
| Grade 0 (normal) | No SH independently of the presence of effusion | No Doppler signal | No SH and no PD signal |
| Grade 1 (minimal) | Minimal hypoechoic SH* up to the level of the horizontal line connecting bone surfaces between the metacarpal head and the proximal phalanx | Up to three single Doppler spots OR up to one confluent spot and two single spots OR up to two confluent spots | Grade 1 hypoechoic SH and ≤ grade 1 PD signal |
| Grade 2 (moderate) | Moderate hypoechoic SH† extending beyond joint line but with the upper surface concave (curved downwards) or hypertrophy extending beyond the joint line but with the upper surface flat | >Grade 1 but | Grade 2 hypoechoic SH and ≤ grade 2 PD signal; or grade 1 SH and a grade 2 PD signal |
| Grade 3 (severe) | Severe hypoechoic SH† with or without effusion extending beyond the joint line but with the upper surface convex (curved upwards) | >Grade 2 (>50% of the total greyscale background) | Grade 3 hypoechoic SH and ≤ grade 3 PD signal; or grade 1 or 2 SH |
*EULAR-OMERACT combined score.
Independently of the presence of effusion.
EULAR-OMERACT, European League Against Rheumatisms–Outcomes Measures in Rheumatology; PD, power Doppler; SH, synovial hypertrophy.
Prevalence of observed lesions, observed agreement, intraobserver and interobserver reliabilities when scoring synovitis in metacarpophalangeal joints on static images
| Intraobserver | Interobserver | |||||||
| Prevalence % | Observed agreement | Kappa range | Kappa range | Prevalence % | Observed agreement | Mean kappa (y/n) | Mean kappa | |
| SH | Grade 0: 9–34 | 0.31–0.94 | −0.01–0.94 | 0.06–0.96 | Grade 0: 22 | 0.76 | 0.57 | 0.78 |
| Grade 1: 11–33 | Grade 1: 21 | |||||||
| Grade 2: 8–47 | Grade 2: 35 | |||||||
| Grade 3: 38–67 | Grade 3: 23 | |||||||
| PD | Grade 0: 59–71 | 0.5–1 | −0.03–1.0 | 0.01–1.0 | Grade 0: 66 | 0.88 | 0.97 | 0.98 |
| Grade 1: 4–15 | Grade 1: 10 | |||||||
| Grade 2: 11–9 | Grade 2: 15 | |||||||
| Grade 3: 5–14 | Grade 3: 9 | |||||||
| Combined score* (SH+PD) | Grade 0: 13–70 | 0.39–1 | −0.01–1.0 | 0.06–1.0 | Grade 0: 32 | 0.81 | 0.80 | 0.79 |
| Grade 1: 4–60 | Grade 1: 20 | |||||||
| Grade 2: 8–45 | Grade 2: 28 | |||||||
| Grade 3: 6–67 | Grade 3: 20 | |||||||
*EULAR-OMERACT combined score.
EULAR-OMERACT, European League Against Rheumatisms–Outcomes Measures in Rheumatology; PD, power Doppler; SH, synovial hypertrophy.
Prevalence of observed lesions, observed agreement and intraobserver reliability when scoring synovitis in MCP joints in patients with RA: standardised scan acquisition versus free scan acquisition
| Standardised scan | Free scan | |||||||
| Prevalence % | Observed agreement (min–max) | Kappa | Prevalence % | Observed agreement | Kappa | |||
| Binary (y/n) | Semiquantitative (0–3) | Binary (y/n) | Semiquantitative (0–3) | |||||
| SH | Grade 0: 0–80 | 0.40–1 | 0.0–1 (−0.21–0.3 | 0.34–1 (0.32–0.45 | Grade 0: 0–55 | 0.50–0.95 | 0.0–1 (−0.01–0.03 | 0.44 |
| Grade 1: 5–45 | Grade 1: 5–55 | |||||||
| Grade 2: 0–50 | Grade 2: 5–65 | |||||||
| Grade 3: 0–15 | Grade 3: 0–5 | |||||||
| PD | Grade 0: 55–95 | 0.65–1 | 0.22–1 (0.21–0.3 | 0.26–1 (0.25–0.29 | Grade 0: 55–90 | 0.65–1 | 0.38–1 (0.36–0.3 | 0.29–1 (−0.21–0.3 |
| Grade 1: 0–30 | Grade 1: 0–25 | |||||||
| Grade 2: 0–10 | Grade 2: 0–15 | |||||||
| Grade 3: 0–5 | Grade 3: 0–20 | |||||||
| Combined score* (SH+PD) | Grade 0: 0–80 | 0.40–1 | 0.39–1 (0.34–0.43 | 0.32–1 (0.29–0.34 | Grade 0: 0–60 | 0.50–0.95 | 0.0–1 (−0.11–0.3 | 0.40–0.93 (0.40–0.52 |
| Grade 1: 10–45 | Grade 1: 5–43 | |||||||
| Grade 2: 0–50 | Grade 2: 0–70 | |||||||
| Grade 3: 0–15 | Grade 3: 0–20 | |||||||
*EULAR-OMERACT combined score.
EULAR-OMERACT, European League Against Rheumatisms–Outcomes Measures in Rheumatology; MCP, metacarpophalangeal; PD, power Doppler; RA, rheumatoid arthritis; SH, synovial hypertrophy.
Prevalence of observed lesions, observed agreement and interobserver reliability when scoring synovitis in MCP joints in patients with RA: standardised scan versus free hand scan
| Standardised scan | Free scan | |||||||||
| Prevalence % (mean) | Binary (yes–no) mean | Semiquantitative (0–3) mean | Prevalence (mean) | Binary (yes–no) mean | Semiquantitative (0–3) mean | |||||
| Observed agreement | Kappa | Observed agreement | Kappa | Observed agreement | Kappa | Observed agreement | Kappa | |||
| SH | Grade 0: 47 | 0.63 | 0.87 | 0.46 | 0.87 | Grade 0: 33 | 0.63 | 0.69 | 0.41 | 0.71 |
| Grade 1: 28 | Grade 1: 30 | |||||||||
| Grade 2: 22 | Grade 2: 33 | |||||||||
| Grade 3: 3 | Grade 3 : 4 | |||||||||
| PD | Grade 0: 84 | 0.88 | 0.76 | 0.83 | 0.79 | Grade 0: 79 | 0.84 | 0.70 | 0.78 | 0.75 |
| Grade 1: 8 | Grade 1: 12 | |||||||||
| Grade 2: 6 | Grade 2: 8 | |||||||||
| Grade 3: 1 | Grade 3: 1 | |||||||||
| Combined score* (SH+PD) | Grade 0: 47 | 0.62 | 0.85 | 0.45 | 0.86 | Grade 0: 35 | 0.64 | 0.74 | 0.40 | 0.73 |
| Grade 1: 29 | Grade 1: 28 | |||||||||
| Grade 2: 21 | Grade 2: 31 | |||||||||
| Grade 3: 3 | Grade 3 : 5 | |||||||||
MCP, metacarpophalangeal; PD, power Doppler; RA, rheumatoid arthritis; SH, synovial hypertrophy.
*EULAR-OMERACT combined score.
EULAR-OMERACT, European League Against Rheumatisms–Outcomes Measures in Rheumatology
Prevalence of observed lesions, observed agreement and intraobserver and interobserver reliabilities when scoring synovitis in non-MCP joints on static images and in patients
| Component | Static images | Patients | ||||||||
| Intra | Inter | Intra | Inter | |||||||
| Kappa range (min–max) (95% CI*) | Observed agreement | Mean kappa (95% CI) | Observed agreement Mean | Prevalence % | Kappa range (min–max) (95% CI) | Observed agreement | Mean kappa (95% CI) | Observed agreement Mean | Prevalence %(mean) | |
| SH score | 0.73–0.9 (0.75 | 0.6–0.95 | 0.6 (0.35 to 0.59) | 0.57 | Grade 0 : 18% | 0.4 | 0.54–0.88 | 0.51 (0.24 to 0.38) | 0.59 | Grade 0 : 60.4 |
| SH detection (yes/no) | 0.64–0.84 (0.63 | 0.68 (0.54 to 0.78) | 0.47 | 0.43 (0.36 to 0.49) | ||||||
| PD score | 0.9–1 (0.94 | 0.88–1 | 0.86 (0.72 to 0.86) | 0.84 | Grade 0 : 24.1% | 0.48 | 0.76–0.94 | 0.61 (0.42 to 0.61) | 0.79 | Grade 0 : 80.4 |
| PD detection (yes/no) | 0.9–1 (0.94 | 0.88 (0.80 to 0.95) | 0.47 | 0.53 (0.43 to 0.60) | ||||||
| Combined score* | 0.75–1 (0.73 | 0.69–1 | 0.65 (0.41 to 0.65) | 0.63 | Grade 0 : 14.9% | 0.42 | 0.54–0.88 | 0.52 (0.36 to 0.52 | 0.60 | Grade 0 : 61.4 |
| Combined score* (SH+PD) | 0.75–0.82 (0.71 | 0.6 (0.5 to 0.58) | 0.45 | 0.51 (0.36 to 0.54) | ||||||
*EULAR-OMERACT combined score.
PD, power Doppler signal; SH, synovial hypertrophy.
Interobserver reliability results for detection and scoring of synovitis components and for the combined PD US score according to the different joints in static images and in patients
| Static images | Patients | |||||||||||
| Wrist | PIP | Knee | MTP | Wrist | PIP | Knee | MTP | |||||
| Mean kappa | Mean kappa | Mean kappa | Mean kappa | Mean | Mean kappa | Mean | Mean kappa | Mean | Mean kappa | Mean | Mean kappa | |
| SH score (0–3) | 0.51 | 0.69 | 0.60 | 0.54 | 0.5 | 0.60 | 0.7 | 0.52 | 0.51 | 0.5 | 0.76 | 0.50 |
| SH detection (yes/no) | 0.35 | 0.74 | 0.81 | 0.64 | 0.23 | 0.2 | 0.42 | 0.34 | ||||
| PD score (0–3) | 0.84 | 0.89 | 0.85 | 0.86 | 0.82 | 0.67 | 0.95 | 0.1 | 0.53 | 0.49 | 0.96 | 0.54 |
| PD detection (yes/no) | 0.91 | 0.92 | 0.83 | 0.89 | 0.42 | 0.1 | 0.41 | 0.48 | ||||
| Combined score* (0–3) | 0.61 | 0.75 | 0.55 | 0.58 | 0.87 | 0.67 | 0.7 | 0.53 | 0.67 | 0.54 | 0.72 | 0.50 |
| Combined score* (SH+PD) | 0.61 | NA | 0.62 | NA | 0.43 | 0.3 | 0.41 | 0.39 | ||||
*EULAR-OMERACT combined score.
MTP, metatarsophalangeal; NA, non-applicable; PD, power Doppler signal; PIP, proximal interphalangeal; SH, synovial hypertrophy.